Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions.
Prescient Therapeutics Ltd
ASX:PTX ISIN:AU000000PTX3
Nouvelles
###
133,990 COMPANY PROFILE VIEWS
- This Page Viewed: (7 derniers jours: 19) (Last 30 Days: 58) (Since Published: 10241)